Heparin enhances the inhibition of factor Xa by protein C inhibitor in the presence but not in the absence of Ca2

Biochemistry

Volumn 48, Issue 5, 2009, Pages 1094-1098

  Sun, Wei ^a   Eriksson, Anna S ^a   Schedin Weiss, Sophia ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT PROPERTIES; FACTOR XA; SERINE PROTEASE INHIBITORS;

AMINO ACIDS; BINDING SITES; CALCIUM; GLYCOPROTEINS; INTERFACES (COMPUTER); POLYSACCHARIDES;

COMPUTER PERIPHERAL EQUIPMENT;

BLOOD CLOTTING FACTOR 10A; CALCIUM; HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR 3; DIVALENT CATION;

ARTICLE; CATALYSIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; PRIORITY JOURNAL; PROTEIN FOLDING; BINDING SITE; CHEMISTRY; COMPARATIVE STUDY; DRUG ANTAGONISM; HUMAN; KINETICS; METABOLISM; PHYSIOLOGY; SPECTROPHOTOMETRY;

BINDING SITES; CALCIUM; CATIONS, DIVALENT; FACTOR XA; HEPARIN; HUMANS; KINETICS; PROTEIN C INHIBITOR; SPECTROPHOTOMETRY;

EID: 61449227347     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi802138m     Document Type: Article

References (45)

1. Silverman, G. A., Bird, P. I., Carrell, R. W., Church, F. C., Coughlin, P. B., Gettins, P. G., Irving, J. A., Lomas, D. A., Luke, C. J., Moyer, R. W., Pemberton, P. A., Remold-O'Donnell, E., Salvesen, G. S., Travis, J., and Whisstock, J. C. (2001) The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276, 33293-33296.
2. Pike, R. N., Bottomley, S. P., Irving, J. A., Bird, P. I., and Whisstock, J. C. (2002) Serpins: Finely balanced conformational traps. IUBMB Life 54, 1-7.
3. Gettins, P. G. (2002) Serpin structure, mechanism, and function. Chem. Rev. 102, 4751-4804.
4. Krebs, M., Uhrin, P., Vales, A., Prendes-Garcia, M. J., Wojta, J., Geiger, M., and Binder, B. R. (1999) Protein C inhibitor is expressed in keratinocytes of human skin. J. Invest. Dermatol. 113, 32-37.
5. Pike, R. N., Buckle, A. M., le Bonniec, B. F., and Church, F. C. (2005) Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans. FEBS J. 272, 4842-4851.
6. Geiger, M. (2007) Protein C. inhibitor, a serpin with functions in-and outside vascular biology. Thromb. Haemostasis 97, 343-347.
7. Geiger, M., Zechmeister-Machhart, M., Uhrin, P., Hufnagl, P., Ecke, S., Priglinger, U., Xu, J., Zheng, X., and Binder, B. R. (1996) Protein C inhibitor (PCI). Immunopharmacology 32, 53-56.
8. Espana, F., Navarro, S., Medina, P., Zorio, E., and Estelles, A. (2007) The role of protein C inhibitor in human reproduction. Semin. Thromb. Hemostasis 33, 41-45.
9. Suzuki, K. (2008) The multi-functional serpin, protein C inhibitor: Beyond thrombosis and hemostasis. J. Thromb. Haemostasis 6, 2017-2026.
10. Hermans, J. M., Jones, R., and Stone, S. R. (1994) Rapid inhibition of the sperm protease acrosin by protein C inhibitor. Biochemistry 33, 5440-5444.
11. Baumgartner, P., Geiger, M., Zieseniss, S., Malleier, J., Huntington, J. A., Hochrainer, K., Bielek, E., Stoeckelhuber, M., Lauber, K., Scherfeld, D., Schwille, P., Waldele, K., Beyer, K., and Engelmann, B. (2007) Phosphatidylethanolamine critically supports internalization of cell-penetrating protein C inhibitor. J. Cell Biol. 179, 793-804.
12. Pratt, C. W., and Church, F. C. (1992) Heparin binding to protein C inhibitor. J. Biol. Chem. 267, 8789-8794.
13. Kazama, Y., Masahiro, N., Yamagishi, R., Takahashi, K., Sakuragawa, N., and Koide, T. (1987) Specificity of sulfated polysaccharides to accelerate the inhibition of activated protein C by protein C inhibitor. Thromb. Res. 48, 179-185.
14. Ecke, S., Geiger, M., and Binder, B. R. (1992) Glycosaminoglycans regulate the enzyme specificity of protein C inhibitor. Ann. N.Y. Acad. Sci. 667, 84-86.
15. Hayashi, T., Nishioka, J., Nakagawa, N., Kamada, H., Gabazza, E. C., Kobayashi, T., Hattori, A., and Suzuki, K. (2007) Protein C inhibitor directly and potently inhibits activated hepatocyte growth factor activator. J. Thromb. Haemostasis 5, 1477-1485.
16. Meijers, J. C., Kanters, D. H., Vlooswijk, R. A., van Erp, H. E., Hessing, M., and Bouma, B. N. (1988) Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. Biochemistry 27, 4231-4237.
17. Espana, F., Gilabert, J., Estelles, A., Romeu, A., Aznar, J., and Cabo, A. (1991) Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. Thromb. Res. 64, 309-320.
18. Li, W., Adams, T. E., Nangalia, J., Esmon, C. T., and Huntington, J. A. (2008) Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-Å structure of the heparin-bridged complex. Proc. Natl. Acad. Sci. U.S.A. 105, 4661-4666.
19. Sun, W., Parry, S., Panico, M., Morris, H. R., Kjellberg, M., Engstrom, A., Dell, A., and Schedin-Weiss, S. (2008) N-Glycans and the N terminus of protein C inhibitor affect the cofactorenhanced rates of thrombin inhibition. J. Biol. Chem. 283, 18601-18611.
20. Aznar, J., Espana, F., Estelles, A., and Royo, M. (1996) Heparin stimulation of the inhibition of activated protein C and other enzymes by human protein C inhibitor: Influence of the molecular weightof heparin and ionic strength. Thromb. Haemostasis 76, 983-988.
21. Laurell, M., Carlson, T. H., and Stenflo, J. (1988) Monoclonal antibodies against the heparin-dependent protein C inhibitor suitable for inhibitor purification and assay of inhibitor complexes. Thromb. Haemostasis 60, 334-339.
22. Laurell, M., and Stenflo, J. (1989) Protein C inhibitor from human plasma: Characterization of native and cleaved inhibitor and demonstration of inhibitor complexes with plasma kallikrein. Thromb. Haemostasis 62, 885-891.
23. Olson, S. T, Björk, I., and Shore, J. D. (1993) Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin. Methods Enzymol. 222, 525-559.
24. Streusand, V. J., Björk, I., Gettins, P. G., Petitou, M., and Olson, S. T. (1995) Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement. J. Biol. Chem. 270, 9043-9051.
25. Rezaie, A. R. (1998) Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa. J. Biol. Chem. 273, 16824-16827.
26. Suzuki, K. (1984) Activated protein C inhibitor. Semin. Thromb. Hemostasis 10, 154-161.
27. Shirk, R. A., Elisen, M. G., Meijers, J. C., and Church, F. C. (1994) Role of the H helix in heparin binding to protein C inhibitor. J. Biol. Chem. 269, 28690-28695.
28. Rezaie, A. R., and Olson, S. T. (2000) Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex. Demonstration by rapid kinetics studies. Biochemistry 39, 12083-12090.
29. Olson, S. T., Swanson, R., Raub-Segall, E., Bedsted, T., Sadri, M., Petitou, M., Herault, J. P., Herbert, J. M., and Björk, I. (2004) Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin. Thromb. Haemostasis 92, 929-939.
30. Yang, L., Manithody, C., and Rezaie, A. R. (2002) Contribution of basic residues of the 70-80-loop to heparin binding and anticoagulant function of activated protein C. Biochemistry 41, 6149-6157.
31. Friedrich, U., Blom, A. M., Dahlback, B., and Villoutreix, B. O. (2001) Structural and energetic characteristics of the heparin-binding site in antithrombotic protein C. J. Biol. Chem. 276, 24122-24128.
32. Marlar, R. A., and Griffin, J. H. (1980) Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease. J. Clin. Invest. 66, 1186-1189.
33. Hayashi, T., Nishioka, J., Kamada, H., Asanuma, K., Kondo, H, Gabazza, E. C., Ido, M., and Suzuki, K. (2004) Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditions. J. Thromb. Haemostasis 2, 949-961.
34. Uhrin, P., Dewerchin, M., Hilpert, M., Chrenek, P., Schofer, C., Zechmeister-Machhart, M., Kronke, G., Vales, A., Carmeliet, P., Binder, B. R., and Geiger, M. (2000) Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility. J. Clin. Invest. 106, 1531-1539.
35. Laurell, M., Christensson, A., Abrahamsson, P. A., Stenflo, J., and Lilja, H. (1992) Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J. Clin. Invest. 89, 1094-1101.
36. He, S., Lin, Y. L., and Liu, Y. X. (1999) Functionally inactive protein C inhibitor in seminal plasma may be associated with infertility. Mol. Hum. Reprod. 5, 513-519.
37. Marlar, R. A., Endres-Brooks, J., and Miller, C. (1985) Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation. Blood 66, 59-63.
38. Espana, F., Vicente, V., Tabernero, D., Scharrer, I., and Griffin, J. H. (1990) Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease. Thromb. Res. 59, 593-608.
39. Tanigawa, M., Wada, H, Minamikawa, K., Wakita, Y., Nagaya, S., Mori, T., Tamaki, S., Nishikawa, H., Kakuta, Y., Nakano, T., et al. (1995) Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction. Am. J. Hematol. 49, 1-5.
40. Bhiladvala, P., Strandberg, K., Stenflo, J., and Holm, J. (2006) Early identification of acute myocardial infarction by activated protein C-protein C inhibitor complex. Thromb. Res. 118, 213-219.
41. Yamada, N., Wada, H., Nakase, T., Minamikawa, K., Nagaya, S., Nakamura, M., Hiraoka, N., Fuzioka, H., Hayashi, T., Suzuki, K., et al. (1995) Hemostatic abnormalities in patients with pulmonary embolism compared with that in deep vein thrombosis. Blood Coagulation Fibrinolysis 6, 627-633.
42. Kolbel, T., Strandberg, K., Mattiasson, I., Stenflo, J., and Lindblad, B. (2006) Activated protein C-protein C inhibitor complex: A new biological marker for aortic aneurysms. J. Vasc. Surg. 43, 935-939.
43. Fujita, M., Izutani, W., and Komurasaki, Y. (2000) Effect of urinary protein C inhibitor on lipopolysaccharide-induced disseminated intravascular coagulation in rats. Thromb. Haemostasis 84, 54-58.
44. Fujita, M., Izutani, W., and Takahashi, K. (2004) Protein C inhibitor as an anti-disseminated intravascular coagulation agent: Mechanism and modification. Curr. Med. Chem.: Cardiovasc. Hematol. Agents 2, 21-27.
45. Nishii, Y., Gabazza, E. C., Fujimoto, H., Nakahara, H., Takagi, T., Bruno, N., D'Alessandro-Gabazza, C. N., Maruyama, J., Maruyama, K., Hayashi, T., Adachi, Y., Suzuki, K., and Taguchi, O. (2006) Protective role of protein C inhibitor in monocrotaline-induced pulmonary hypertension. J. Thromb. Haemostasis 4, 2331-2339.